Publication | Open Access
Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis
60
Citations
19
References
2021
Year
In maintenance HD patients, humoral response against SARS-CoV-2 was boosted after a third dose of BNT162b2, allowing seroconversion in more than half of non-responders. These data may support an intensified vaccination protocol with a third dose of BNT162b2 in dialysis patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1